The versatile and tunable ligand-exchange dynamics in ruthenium-(II)-polypyridyl complexes imposed by the modulation of the steric and electronic effects of the coordinated ligands provide an unlimited scope for developing phototherapeutic agents. The photorelease of a bidentate ligand from the Ru-center is better suited for potent Ru(II)-based photocytotoxic agents with two available labile sites for cross-linking with biological targets augmented with possible phototriggered 1 O 2 generation. Herein, we introduced a phenyl-terpyridine (ptpy) ligand in the octahedral Ru(II) core of [Ru(ptpy)(L−L)Cl] + to induce structural distortion for the possible photorelease of electronically distinct bidentate ligands (L−L). For a systematic study, we designed four Ru(II) polypyridyl complexes: [Ru(ptpy)(L−L)Cl](PF 6 ), ([1]−[4]), where L−L = 1,2-bis(phenylthio)ethane (SPH) [1], N,N,N′,N′-tetramethylethylenediamine (TMEN) [2], N1,N2-diphenylethane-1,2-diimine (BPEDI) [3], and bis[2-(diphenylphosphino)phenyl]ether (DPE-Phos) [4]. The detailed photochemical studies suggest a single-step dissociation of L−L from the bis-thioether (SPH) complex [1] and diamine (TMEN) complex [2], while no photosubstitution was observed for [3] and [4]. Complex [1] and [2] demonstrated a dual role, involving both photosubstitution and 1 O 2 generation, while [3] and [4] solely exhibited poor to moderate 1 O 2 production. The interplay of excited states leading to these behaviors was rationalized from the lifetimes of the 3 MLCT excited states by using transient absorption spectroscopy, suggesting intricate relaxation dynamics and 1 O 2 generation upon excitation. Therefore, the photolabile complexes [1] and [2] could potentially act as dual photoreactive agents via the phototriggered release of L−L (PACT) and/or 1 O 2 -mediated PDT mechanisms, while [4] primarily can be utilized as a PDT agent.